Recent Blogs

NPI to contact domain data release

By Alma Trotter | April 20, 2021

CareSet Journal is releasing data that links NPI records to the contact domains submitted by providers in their NPI applications. For example, when Jane Smith applied for an NPI, she provided a contact email of “jane.smith@examplehospital.com”. In this data, her NPI will be listed alongside the domain of “examplehospital.com”. If you want to dive straight…

Read More

I got the COVID-19 vaccine and this is what happened

By Alma Trotter | March 3, 2021

I am a Mexicana, and I participated in one of the SARS-CoV-2 vaccine trials! Unfortunately, I was a placebo arm. Now, I’m fully vaccinated! This is my experience after receiving both injections.  There have been efforts by the FDA to increase the participation of historically underrepresented groups in clinical trials. Kaiser Health News discussed how…

Read More

Finally Unblinded from the COVID-19 Vaccine Trial

By Alma Trotter | February 19, 2021

September 2020, I made the decision to participate in one of the SARS-CoV-2 vaccine trials. There is still vaccine hesitancy. My participation in this trial, along with my blog posts, are all in hopes of increasing transparency, and building trust within the trial community. You can follow my journey beginning with my first blog.  When…

Read More

CareSet Collects COVID Collaborators

By Fred Trotter | December 8, 2020

Last night, HHS released COVID-19 capacity data at the hospital-level. Previously, this data had only been available on a state level.  CareSet had early access to the hospital data in order to help create the Facility COVID PUF Community Frequently Asked Questions document. It is available on our GitHub page. If you have questions about…

Read More

Participating in the COVID-19 vaccine trial part 3

By Alma Trotter | November 23, 2020

I thought it was pertinent I take the chance and sign up for the SARS-CoV-2 vaccine trial. This summer I began my journey. The trial I’m in contains two separate injections several weeks apart. It’s been a month since my second injection. The question remains, am I safe from COVID-19? Spontaneous, or reckless? Jumping into…

Read More

Participating in the COVID-19 vaccine trial part two

By Alma Trotter | October 23, 2020

Working with life science organizations who create vaccines that help patients, I thought it was apt to immerse myself in the vaccine approval process given the opportunity. I signed up for the SARS-CoV-2 vaccine trial. I wrote about the beginning of this vaccination journey, and below is the first follow-up post of this two-year dedication…

Read More

For science, for the world – participating in the COVID-19 vaccine trial

By Alma Trotter | October 13, 2020

It’s one thing to participate in a scientific study. But to participate in a vaccine trial for a virus in the middle of a pandemic around said virus? This is a once in a lifetime opportunity! I’ll be writing a series on my experience participating in a SARS-CoV-2 trial. Since vaccines are one of CareSet’s…

Read More

COVID-19, Data and Nursing Homes

By Alma Trotter | July 28, 2020

In my last post, I briefly touched on COVID-19 and older adults. In this post, I will take a short, basic data tour of the skilled nursing home COVID-19 data made available by the CDC.  COVID-19 and Nursing Homes Late February, in Washington state, Stat News reported the first COVID-19 death in a nursing facility,…

Read More

What Does COVID-19 Look Like for Black, Hispanic, and Indigenous People?

By Alma Trotter | June 25, 2020

COVID-19 and Black, Hispanic, and Indigenous People Last month, Americans were protesting against the stay-at-home orders in the name of opening the economy as unemployment rates steadily increased. Looking at Twitter, you’ll see many tweets like the one below, pining to reopen. People are aching to go back to “normal.” Looking at data, especially for…

Read More

Which Medicare Physician is the Best Doctor to Educate About Your Medication or Medical Device?

By Ashish Patel | May 22, 2020

While pharma marketers continue to navigate their brand through COVID-19, non-personal promotion appears to be the best approach for the time being. In order to reach optimal efficiency, marketers will want to utilize the best list of providers for their brand. Publicly available datasets, as well as commercially available datasets, are all over the internet.…

Read More